Ocular Ischemic Syndrome (OIS) is a serious eye condition that can cause vision loss. It is caused by a decrease in blood flow to the eye, which can lead to a variety of problems, including damage to the retina, optic nerve, and other parts of the eye. OIS is often referred to as the “silent thief” because it can cause vision loss without any warning signs or symptoms. In this article, we will discuss what OIS is, the causes and risk factors, diagnosis, and treatment options.
Ocular Ischemic Syndrome is a condition that occurs when there is a decrease in the blood supply to the eye. This decrease in blood flow can be caused by a variety of factors, including blockages in the arteries that supply blood to the eye, narrowing of the blood vessels, or damage to the blood vessels. OIS can cause damage to the retina, optic nerve, and other parts of the eye, which can lead to vision loss.
There are several potential causes of OIS, including blockages in the arteries that supply blood to the eye, narrowing of the blood vessels, or damage to the blood vessels. Other risk factors for OIS include diabetes, high blood pressure, high cholesterol, smoking, and advanced age.
OIS can be difficult to diagnose because it often does not cause any symptoms. However, if you are experiencing any vision problems, it is important to see an eye doctor. Your doctor will perform a comprehensive eye exam to look for signs of OIS. This may include tests to measure the pressure inside the eye, an optical coherence tomography (OCT) to look for signs of damage to the retina, and a fluorescein angiography to look for blockages in the blood vessels.
The treatment for OIS depends on the underlying cause. If the cause is a blockage in the blood vessels, your doctor may recommend a procedure to open the blocked vessels. Other treatments may include medications to reduce inflammation, medications to lower blood pressure or cholesterol, or laser treatment to improve blood flow.
Ocular Ischemic Syndrome is a serious eye condition that can cause vision loss. It is caused by a decrease in blood flow to the eye, which can lead to a variety of problems, including damage to the retina, optic nerve, and other parts of the eye. OIS is often referred to as the “silent thief” because it can cause vision loss without any warning signs or symptoms. If you are experiencing any vision problems, it is important to see an eye doctor for a comprehensive eye exam. Treatment for OIS depends on the underlying cause, and may include medications, procedures, or laser treatment.
1.
Next Day Mood Is Affected by Ability to Recover From Work.
2.
Enhanced CAR T cell therapy offers new strategy for lymphoma
3.
With the use of a novel sequencing technique, pediatric bone marrow transplant mortality can be predicted by analyzing lung microbiomes.
4.
Decrease seen in in situ breast cancer since 2009
5.
Scientists hail the cervical cancer treatment as the most remarkable breakthrough in 20 years.
1.
Discovering the Benefits of TNK: A Comprehensive Blog Article
2.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
3.
Revolutionizing Cancer Treatment with Darzalex: How an Innovative Drug is Transforming Lives
4.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
5.
Precision Medicine and Genomics: Revolutionizing Healthcare Through Personalized Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
2.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
3.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
4.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
5.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation